MARAVIROC

MARAVIROC was reported 2293 times

MARAVIROC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HIV TROPISM IDENTIFIED 2 1.0000
1 CCR5 RECEPTOR POSITIVE 2 1.0000
2 ARTERIOVENOUS GRAFT SITE PSEUDOANEURYSM 3 0.6000
3 ANTIRETROVIRAL THERAPY 1 0.5000
4 LENTICULAR OPERATION 2 0.2222
5 ANTIVIRAL DRUG LEVEL BELOW THERAPEUTIC 8 0.2162
6 PITUITARY HYPERPLASIA 2 0.2000
7 CSF HIV ESCAPE SYNDROME 15 0.1087
8 CONGENITAL URETERIC ANOMALY 6 0.0968
9 CONGENITAL VESICOURETERIC REFLUX 7 0.0814
10 MYCOBACTERIUM AVIUM COMPLEX IMMUNE RESTORATION DISEASE 2 0.0690
11 NEUROPATHIC ULCER 3 0.0556
12 PENIS CARCINOMA 2 0.0526
13 CONGENITAL BLADDER ANOMALY 7 0.0519
14 AIDS DEMENTIA COMPLEX 3 0.0492
15 ANAL CANCER RECURRENT 1 0.0476
16 MITOCHONDRIAL MYOPATHY ACQUIRED 3 0.0462
17 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 5 0.0450
18 EYE INFECTION SYPHILITIC 2 0.0426
19 BLOOD GONADOTROPHIN INCREASED 1 0.0400
20 HIV VIRAEMIA 8 0.0381
21 HYPERPHOSPHATASAEMIA 4 0.0364
22 VIRAL MUTATION IDENTIFIED 128 0.0347
23 VIRAL LOAD ABNORMAL 6 0.0343
24 VIRAL LOAD DECREASED 5 0.0342
25 ANAL CANCER STAGE 0 1 0.0323
26 METAPNEUMOVIRUS PNEUMONIA 3 0.0312
27 CONGENITAL RENAL DISORDER 8 0.0301
28 MITOCHONDRIAL MYOPATHY 6 0.0275
29 VIROLOGIC FAILURE 141 0.0262
30 CENTRAL NERVOUS SYSTEM IMMUNE RECONSTITUTION INFLAMMATORY RESPONSE 1 0.0238
31 CEREBRAL HAEMORRHAGE TRAUMATIC 1 0.0227
32 ANAL CANCER STAGE III 1 0.0227
33 AUDITORY NERVE DISORDER 1 0.0227
34 SECONDARY SYPHILIS 2 0.0202
35 ANOGENITAL DYSPLASIA 3 0.0200
36 CSF TEST ABNORMAL 10 0.0199
37 BLOOD HIV RNA 1 0.0192
38 HODGKIN'S DISEASE 13 0.0179
39 ARTERIOVENOUS GRAFT SITE INFECTION 1 0.0179
40 CHOLESTASIS OF PREGNANCY 8 0.0174
41 VIRAL LOAD 3 0.0173
42 CASTLEMAN'S DISEASE 1 0.0172
43 DERMATOPHYTOSIS OF NAIL 2 0.0168
44 PRIMARY ADRENAL INSUFFICIENCY 5 0.0164
45 PNEUMOCOCCAL BACTERAEMIA 2 0.0159
46 EXTERNAL EAR CELLULITIS 2 0.0157
47 ANGIOLIPOMA 1 0.0156
48 ACUTE HEPATITIS B 5 0.0151
49 CD8 LYMPHOCYTES DECREASED 3 0.0149
50 BLOOD HIV RNA INCREASED 27 0.0149
51 SUPERINFECTION BACTERIAL 11 0.0139
52 PATHOGEN RESISTANCE 125 0.0137
53 NASAL ABSCESS 3 0.0130
54 ANAL SQUAMOUS CELL CARCINOMA 4 0.0130
55 ANAPLASTIC LARGE-CELL LYMPHOMA 3 0.0127
56 CONGENITAL CYSTIC KIDNEY DISEASE 10 0.0118
57 ACQUIRED IMMUNODEFICIENCY SYNDROME 6 0.0116
58 LIPODYSTROPHY ACQUIRED 24 0.0113
59 SYPHILIS 8 0.0110
60 ACUTE HEPATITIS C 2 0.0109
61 TRICHODYSPLASIA SPINULOSA 4 0.0105
62 ANAPHYLACTOID SYNDROME OF PREGNANCY 1 0.0104
63 BONE DEMINERALISATION 11 0.0104
64 BACTERIAL PROSTATITIS 1 0.0101
65 ARTERIAL SPASM 2 0.0101
66 BURKITT'S LYMPHOMA 1 0.0095
67 IMMUNE RECONSTITUTION SYNDROME 12 0.0093
68 RASH SCARLATINIFORM 2 0.0090
69 GENOTYPE DRUG RESISTANCE TEST POSITIVE 9 0.0088
70 BENIGN SALIVARY GLAND NEOPLASM 1 0.0086
71 CONGENITAL HYDRONEPHROSIS 6 0.0084
72 NONINFECTIVE ENCEPHALITIS 6 0.0083
73 CONGENITAL PYELOCALIECTASIS 1 0.0083
74 KIDNEY ENLARGEMENT 9 0.0083
75 ANAL CANCER 8 0.0082
76 BULLOUS LUNG DISEASE 1 0.0080
77 VIRAL LOAD INCREASED 30 0.0077
78 RECTAL NEOPLASM 2 0.0076
79 HEPATITIS B DNA INCREASED 5 0.0074
80 LABILE HYPERTENSION 2 0.0072
81 CRYPTOCOCCAL FUNGAEMIA 1 0.0070
82 SECONDARY HYPERTENSION 2 0.0070
83 BONE METABOLISM DISORDER 2 0.0066
84 CONGENITAL CHOROID PLEXUS CYST 2 0.0066
85 HEPATOBILIARY DISEASE 4 0.0064
86 WHITE MATTER LESION 8 0.0063
87 VAGINAL CANCER 2 0.0063
88 BLOOD CHLORIDE ABNORMAL 1 0.0062
89 CD4 LYMPHOCYTES DECREASED 13 0.0061
90 CENTRAL NERVOUS SYSTEM INFLAMMATION 2 0.0060
91 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 30 0.0060
92 CARCINOMA IN SITU 1 0.0060
93 KAPOSI'S SARCOMA 3 0.0060
94 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 2 0.0060
95 CHOLELITHIASIS OBSTRUCTIVE 1 0.0060
96 GIARDIASIS 2 0.0059
97 CARDIAC OUTPUT INCREASED 1 0.0058
98 ATHETOSIS 1 0.0057
99 HIV INFECTION 17 0.0056
100 PLASMABLASTIC LYMPHOMA 2 0.0056
101 CORONARY ARTERY INSUFFICIENCY 2 0.0056
102 TOXOPLASMOSIS 6 0.0056
103 MULTIPLE-DRUG RESISTANCE 17 0.0055
104 CENTRAL LINE INFECTION 2 0.0054
105 FANCONI SYNDROME ACQUIRED 9 0.0051
106 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 1 0.0049
107 SQUAMOUS CELL CARCINOMA OF THE ORAL CAVITY 2 0.0049
108 NEONATAL TACHYPNOEA 2 0.0048
109 CHORIORETINAL ATROPHY 1 0.0048
110 SYNDACTYLY 4 0.0048
111 DRUG LEVEL CHANGED 3 0.0048
112 CD4 LYMPHOCYTES ABNORMAL 1 0.0048
113 GENERALISED ANXIETY DISORDER 7 0.0048
114 ADRENAL SUPPRESSION 4 0.0047
115 DIABETIC HYPEROSMOLAR COMA 2 0.0046
116 NON-HODGKIN'S LYMPHOMA 6 0.0046
117 HIV TEST POSITIVE 3 0.0045
118 PRECANCEROUS CONDITION 3 0.0045
119 CD4 LYMPHOCYTES INCREASED 1 0.0043
120 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 35 0.0042
121 CEREBELLAR ATAXIA 4 0.0042
122 CONGENITAL SKIN DIMPLES 1 0.0041
123 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 1 0.0041
124 ACUTE HIV INFECTION 1 0.0040
125 CHLAMYDIAL INFECTION 3 0.0040
126 CHRONIC DISEASE 1 0.0039
127 KELOID SCAR 2 0.0039
128 CRYPTOSPORIDIOSIS INFECTION 2 0.0038
129 DYSLIPIDAEMIA 19 0.0037
130 BLEEDING VARICOSE VEIN 2 0.0037
131 ARTERIAL STENT INSERTION 1 0.0037
132 HEPATITIS A 3 0.0035
133 CERVIX CARCINOMA STAGE 0 1 0.0035
134 LEGIONELLA INFECTION 2 0.0035
135 HYPERLEUKOCYTOSIS 3 0.0034
136 VULVAL CANCER 2 0.0034
137 ANOGENITAL WARTS 3 0.0034
138 VITRECTOMY 2 0.0034
139 DRUG RESISTANCE 85 0.0033
140 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 5 0.0033
141 LYMPH NODE PAIN 6 0.0032
142 CHRONIC HEPATITIS B 1 0.0032
143 JC VIRUS INFECTION 5 0.0031
144 NECROTISING RETINITIS 2 0.0031
145 ALLERGY TO ARTHROPOD BITE 1 0.0031
146 ACTIVITIES OF DAILY LIVING DECREASED 2 0.0031
147 MIXED LIVER INJURY 9 0.0030
148 VIRAEMIA 4 0.0029
149 FUSARIUM INFECTION 2 0.0029
150 MALARIA 2 0.0028
151 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
152 ESCHERICHIA URINARY TRACT INFECTION 12 0.0028
153 LABELLED DRUG-DRUG INTERACTION ISSUE 4 0.0028
154 CYTOLYTIC HEPATITIS 9 0.0027
155 CENTRAL OBESITY 2 0.0027
156 SCOTOMA 2 0.0027
157 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
158 WEST NILE VIRAL INFECTION 2 0.0027
159 POLYDACTYLY 3 0.0026
160 AORTIC RUPTURE 1 0.0026
161 CEREBRAL ARTERIOSCLEROSIS 1 0.0026
162 ATROPHY 5 0.0026
163 CYTOMEGALOVIRUS CHORIORETINITIS 5 0.0026
164 PLACENTA PRAEVIA 2 0.0025
165 GENE MUTATION 5 0.0025
166 LYMPHANGITIS 2 0.0025
167 RENAL TUBULAR DISORDER 7 0.0025
168 QUADRIPLEGIA 5 0.0024
169 ANHEDONIA 62 0.0024
170 APPARENT LIFE THREATENING EVENT 1 0.0024
171 ABDOMINAL SEPSIS 2 0.0023
172 TRANSPLANT DYSFUNCTION 4 0.0022
173 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
174 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
175 PRURIGO 2 0.0022
176 CARDIAC PACEMAKER REPLACEMENT 1 0.0022
177 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 5 0.0021
178 ESCHERICHIA BACTERAEMIA 5 0.0021
179 LIVE BIRTH 17 0.0020
180 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
181 LYMPHOEDEMA 14 0.0020
182 ULNA FRACTURE 2 0.0020
183 SKIN STRIAE 3 0.0020
184 CONGENITAL HYDROCEPHALUS 1 0.0020
185 PERIPHERAL VENOUS DISEASE 8 0.0020
186 PROTEIN TOTAL INCREASED 5 0.0019
187 BLOOD GASES ABNORMAL 1 0.0019
188 BODY FAT DISORDER 1 0.0018
189 ECONOMIC PROBLEM 28 0.0018
190 OSTEOPENIA 28 0.0018
191 BK VIRUS INFECTION 6 0.0018
192 BLOOD AMYLASE INCREASED 3 0.0018
193 PUPILS UNEQUAL 2 0.0017
194 MYCOBACTERIAL INFECTION 3 0.0017
195 MENINGITIS CRYPTOCOCCAL 3 0.0017
196 SYSTEMIC MYCOSIS 2 0.0017
197 HISTOPLASMOSIS 3 0.0017
198 ENCEPHALITIS VIRAL 2 0.0016
199 RECTAL CANCER 5 0.0016
200 PSYCHIATRIC SYMPTOM 12 0.0016
201 RENAL ATROPHY 2 0.0016
202 DERMATITIS EXFOLIATIVE 8 0.0016
203 SQUAMOUS CELL CARCINOMA 15 0.0016
204 ABORTION MISSED 2 0.0016
205 NEUROLOGICAL SYMPTOM 9 0.0016
206 ADENOCARCINOMA PANCREAS 2 0.0016
207 CHANGE IN SEIZURE PRESENTATION 1 0.0015
208 ACQUIRED GENE MUTATION 2 0.0015
209 POLYDIPSIA 6 0.0015
210 INTERCEPTED PRODUCT PRESCRIBING ERROR 2 0.0015
211 OESOPHAGEAL CANDIDIASIS 6 0.0015
212 LIPIDS INCREASED 3 0.0015
213 GLYCOSURIA 2 0.0015
214 URETERIC OBSTRUCTION 2 0.0015
215 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0014
216 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 2 0.0014
217 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
218 RENAL TRANSPLANT 5 0.0014
219 CALCULUS URETERIC 1 0.0014
220 FAT TISSUE INCREASED 2 0.0014
221 CERVICAL DYSPLASIA 3 0.0014
222 CLONIC CONVULSION 1 0.0014
223 CHOLANGIOCARCINOMA 2 0.0013
224 HYPERLIPIDAEMIA 16 0.0013
225 ALLERGIC COUGH 1 0.0013
226 NEUROLOGICAL DECOMPENSATION 3 0.0013
227 NEURITIS 2 0.0013
228 OSTEOMALACIA 2 0.0013
229 MYELITIS 2 0.0013
230 PATELLA FRACTURE 3 0.0013
231 BREAST FEEDING 1 0.0013
232 CHRONIC ALLOGRAFT NEPHROPATHY 1 0.0013
233 HYPERBILIRUBINAEMIA 13 0.0013
234 BREAST CALCIFICATIONS 1 0.0013
235 INTRA-UTERINE DEATH 2 0.0012
236 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
237 ADRENAL MASS 1 0.0012
238 HYPERTRIGLYCERIDAEMIA 7 0.0012
239 BLADDER NEOPLASM 2 0.0012
240 AXONAL NEUROPATHY 1 0.0011
241 ABDOMINAL NEOPLASM 1 0.0011
242 ANAEMIA OF CHRONIC DISEASE 1 0.0011
243 ANEURYSM RUPTURED 1 0.0011
244 METAMORPHOPSIA 2 0.0011
245 LOBAR PNEUMONIA 2 0.0011
246 ADENOCARCINOMA OF COLON 2 0.0011
247 BONE DENSITY DECREASED 33 0.0011
248 MYELOPATHY 2 0.0011
249 MYOPATHY 9 0.0010
250 TREATMENT NONCOMPLIANCE 57 0.0010
251 CARDIOPULMONARY FAILURE 4 0.0010
252 PARKINSONISM 10 0.0010
253 PNEUMONIA STAPHYLOCOCCAL 2 0.0010
254 HYPERTRANSAMINASAEMIA 7 0.0010
255 IMMUNODEFICIENCY 15 0.0010
256 ACQUIRED HAEMOPHILIA 1 0.0010
257 EXPOSURE DURING PREGNANCY 62 0.0010
258 HEPATITIS B 6 0.0010
259 HEPATITIS C 12 0.0010
260 PATHOLOGICAL FRACTURE 5 0.0010
261 WEIGHT LOSS POOR 5 0.0010
262 ABORTION SPONTANEOUS 39 0.0010
263 CACHEXIA 5 0.0010
264 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6 0.0010
265 HYPERPARATHYROIDISM 2 0.0010
266 LUNG ABSCESS 2 0.0010
267 BRAIN OEDEMA 12 0.0009
268 POLYARTHRITIS 5 0.0009
269 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 2 0.0009
270 CUSHINGOID 3 0.0009
271 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
272 ORAL CANDIDIASIS 12 0.0009
273 LYMPHOMA 14 0.0009
274 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
275 LYME DISEASE 3 0.0009
276 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
277 ADENOCARCINOMA 2 0.0009
278 RENAL COLIC 2 0.0009
279 CARBON DIOXIDE DECREASED 1 0.0009
280 HEPATIC FAILURE 26 0.0009
281 EMBOLIC STROKE 3 0.0009
282 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
283 FIBRIN D DIMER INCREASED 3 0.0008
284 BACTERAEMIA 10 0.0008
285 PROTEINURIA 16 0.0008
286 BILE DUCT STENOSIS 1 0.0008
287 CHRONIC GRAFT VERSUS HOST DISEASE 3 0.0008
288 STILLBIRTH 4 0.0008
289 GUILLAIN-BARRE SYNDROME 4 0.0008
290 OSTEOPOROSIS 34 0.0008
291 VITAMIN D DEFICIENCY 8 0.0008
292 CEREBRAL DISORDER 6 0.0008
293 AORTIC VALVE REPLACEMENT 1 0.0008
294 ERYSIPELAS 4 0.0008
295 BREECH PRESENTATION 1 0.0008
296 METASTASES TO PERITONEUM 2 0.0008
297 BLOOD BILIRUBIN ABNORMAL 1 0.0008
298 OESOPHAGEAL ULCER 3 0.0008
299 TREATMENT FAILURE 64 0.0008
300 ADJUSTMENT DISORDER 1 0.0008
301 ANGINA UNSTABLE 5 0.0008
302 ACROCHORDON 1 0.0008
303 AREFLEXIA 2 0.0007
304 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
305 BODY MASS INDEX INCREASED 1 0.0007
306 NORMAL NEWBORN 4 0.0007
307 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
308 POLYURIA 6 0.0007
309 DEMYELINATION 3 0.0007
310 MULTIPLE FRACTURES 12 0.0007
311 HYPERURICAEMIA 3 0.0007
312 SPINAL COMPRESSION FRACTURE 6 0.0007
313 CHRONIC KIDNEY DISEASE 55 0.0007
314 VITREOUS HAEMORRHAGE 2 0.0007
315 BILIARY TRACT DISORDER 1 0.0007
316 ENCEPHALITIS 5 0.0007
317 RASH MORBILLIFORM 2 0.0007
318 ENDOTRACHEAL INTUBATION 2 0.0007
319 NEPHROPATHY TOXIC 8 0.0007
320 DRUG TOLERANCE DECREASED 2 0.0007
321 PREMATURE LABOUR 4 0.0007
322 AUDITORY DISORDER 1 0.0007
323 LUNG NEOPLASM 3 0.0007
324 EXERCISE TOLERANCE DECREASED 4 0.0007
325 ADENOVIRUS INFECTION 2 0.0007
326 CAESAREAN SECTION 8 0.0007
327 LUMBAR SPINAL STENOSIS 2 0.0007
328 MAJOR DEPRESSION 5 0.0007
329 SPINAL OSTEOARTHRITIS 6 0.0007
330 ACUTE MYOCARDIAL INFARCTION 20 0.0007
331 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15 0.0007
332 STEVENS-JOHNSON SYNDROME 15 0.0007
333 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
334 CREPITATIONS 2 0.0007
335 LUNG ADENOCARCINOMA 2 0.0007
336 CYTOMEGALOVIRUS INFECTION 11 0.0007
337 ADRENAL INSUFFICIENCY 8 0.0007
338 HYPERTHERMIA 5 0.0007
339 CALCULUS URINARY 1 0.0006
340 RENAL FAILURE CHRONIC 5 0.0006
341 DECREASED ACTIVITY 7 0.0006
342 BRONCHIAL DISORDER 1 0.0006
343 TIBIA FRACTURE 3 0.0006
344 GESTATIONAL DIABETES 3 0.0006
345 BLOOD CREATINE PHOSPHOKINASE INCREASED 18 0.0006
346 HUMERUS FRACTURE 3 0.0006
347 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
348 ENTEROCOCCAL INFECTION 3 0.0006
349 HEPATITIS ACUTE 4 0.0006
350 HERPES SIMPLEX 4 0.0006
351 HYPOVENTILATION 2 0.0006
352 SMALL FOR DATES BABY 3 0.0006
353 DRUG LEVEL INCREASED 10 0.0006
354 ACUTE CORONARY SYNDROME 5 0.0006
355 EMOTIONAL DISTRESS 73 0.0006
356 BLOOD CALCIUM ABNORMAL 1 0.0006
357 SPLENOMEGALY 7 0.0006
358 PLANTAR FASCIITIS 2 0.0006
359 QUALITY OF LIFE DECREASED 8 0.0006
360 POTENTIATING DRUG INTERACTION 2 0.0006
361 FOETAL EXPOSURE DURING PREGNANCY 48 0.0006
362 WRIST FRACTURE 7 0.0006
363 SKIN LESION 16 0.0006
364 ACUTE SINUSITIS 1 0.0006
365 AMYLOIDOSIS 1 0.0006
366 POLYMENORRHOEA 2 0.0006
367 MALABSORPTION 3 0.0006
368 DEPRESSIVE SYMPTOM 2 0.0006
369 NEONATAL RESPIRATORY DISTRESS SYNDROME 2 0.0006
370 HAEMARTHROSIS 5 0.0006
371 APPARENT DEATH 2 0.0006
372 DRUG INTERACTION 86 0.0005
373 RENAL FAILURE ACUTE 23 0.0005
374 AMYLASE INCREASED 2 0.0005
375 BLOOD CHOLESTEROL DECREASED 1 0.0005
376 PANCYTOPENIA 30 0.0005
377 BONE DENSITY ABNORMAL 2 0.0005
378 AUTOIMMUNE THYROIDITIS 2 0.0005
379 HEPATOCELLULAR CARCINOMA 4 0.0005
380 ARTERIAL DISORDER 1 0.0005
381 CLAVICLE FRACTURE 2 0.0005
382 ADRENAL DISORDER 1 0.0005
383 BLOOD BILIRUBIN INCREASED 14 0.0005
384 ARTERIAL THROMBOSIS 1 0.0005
385 PERIPHERAL SENSORY NEUROPATHY 3 0.0005
386 CERVIX CARCINOMA 2 0.0005
387 PULMONARY HAEMORRHAGE 4 0.0005
388 PNEUMONIA FUNGAL 2 0.0005
389 SEPTIC SHOCK 22 0.0005
390 PATENT DUCTUS ARTERIOSUS 2 0.0005
391 PREMATURE DELIVERY 8 0.0005
392 ANORECTAL DISORDER 1 0.0005
393 POLYNEUROPATHY 6 0.0005
394 HEPATITIS CHOLESTATIC 3 0.0005
395 INTRACRANIAL ANEURYSM 2 0.0005
396 CYSTITIS HAEMORRHAGIC 2 0.0005
397 RASH MACULO-PAPULAR 11 0.0005
398 END STAGE RENAL DISEASE 9 0.0005
399 PERIPHERAL ISCHAEMIA 2 0.0005
400 RENAL IMPAIRMENT 41 0.0005
401 CHOLANGITIS 3 0.0005
402 CHEST INJURY 1 0.0005
403 PULSELESS ELECTRICAL ACTIVITY 2 0.0005
404 FOOT FRACTURE 9 0.0005
405 LABORATORY TEST ABNORMAL 14 0.0005
406 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
407 ANAEMIA MACROCYTIC 1 0.0005
408 BONE LOSS 7 0.0005
409 DYSURIA 17 0.0005
410 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
411 PULMONARY THROMBOSIS 5 0.0005
412 ASPERGILLUS INFECTION 3 0.0005
413 OSTEONECROSIS 15 0.0005
414 CEREBELLAR SYNDROME 1 0.0005
415 CORNEAL DISORDER 1 0.0005
416 HYPOXIA 16 0.0005
417 CATHETERISATION CARDIAC 2 0.0005
418 NERVE INJURY 5 0.0004
419 RHINITIS ALLERGIC 2 0.0004
420 MALIGNANT MELANOMA 6 0.0004
421 MALNUTRITION 5 0.0004
422 INTESTINAL PERFORATION 5 0.0004
423 BLOOD ALKALINE PHOSPHATASE INCREASED 11 0.0004
424 REBOUND EFFECT 5 0.0004
425 VASCULAR DEVICE INFECTION 2 0.0004
426 OBESITY 7 0.0004
427 NEPHROTIC SYNDROME 3 0.0004
428 LUMBAR VERTEBRAL FRACTURE 2 0.0004
429 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
430 ISCHAEMIA 2 0.0004
431 TOOTH LOSS 9 0.0004
432 APHTHOUS STOMATITIS 1 0.0004
433 AUTOIMMUNE HEPATITIS 3 0.0004
434 HEPATIC ENCEPHALOPATHY 4 0.0004
435 NEPHROPATHY 4 0.0004
436 BILIRUBIN CONJUGATED INCREASED 1 0.0004
437 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
438 RASH GENERALISED 11 0.0004
439 BLOOD PROLACTIN INCREASED 2 0.0004
440 SUBCUTANEOUS ABSCESS 2 0.0004
441 MATERNAL EXPOSURE DURING PREGNANCY 37 0.0004
442 NEPHROLITHIASIS 19 0.0004
443 BLOOD CREATININE INCREASED 27 0.0004
444 BREATH ODOUR 1 0.0004
445 BRONCHITIS CHRONIC 1 0.0004
446 RHABDOMYOLYSIS 17 0.0004
447 TRANSAMINASES INCREASED 9 0.0004
448 HYDRONEPHROSIS 3 0.0004
449 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
450 CORONARY ARTERY STENOSIS 2 0.0004
451 KLEBSIELLA INFECTION 2 0.0004
452 BRAIN ABSCESS 1 0.0004
453 THIRST 7 0.0004
454 PETIT MAL EPILEPSY 2 0.0004
455 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
456 PHLEBITIS 2 0.0004
457 DIFFUSE LARGE B-CELL LYMPHOMA 3 0.0004
458 BLOOD CHLORIDE DECREASED 1 0.0004
459 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
460 TYPE 2 DIABETES MELLITUS 13 0.0004
461 NERVOUS SYSTEM DISORDER 12 0.0004
462 BLOOD POTASSIUM ABNORMAL 1 0.0004
463 NEOPLASM PROGRESSION 13 0.0004
464 ABDOMINAL MASS 1 0.0004
465 HEPATIC CIRRHOSIS 7 0.0004
466 BLOOD POTASSIUM INCREASED 6 0.0004
467 ASPIRATION 4 0.0004
468 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
469 RENAL FAILURE 48 0.0004
470 INTRACRANIAL PRESSURE INCREASED 2 0.0004
471 ATRIAL SEPTAL DEFECT 3 0.0004
472 EYE INFECTION 4 0.0004
473 HEPATOCELLULAR INJURY 5 0.0004
474 GENERALISED ERYTHEMA 2 0.0004
475 MYOCARDIAL ISCHAEMIA 4 0.0004
476 MICTURITION URGENCY 4 0.0003
477 SKIN ATROPHY 2 0.0003
478 ENTEROCOLITIS 2 0.0003
479 BLOOD URIC ACID INCREASED 2 0.0003
480 MYELODYSPLASTIC SYNDROME 5 0.0003
481 APATHY 5 0.0003
482 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
483 METASTASES TO LIVER 6 0.0003
484 RIB FRACTURE 7 0.0003
485 IMMUNOSUPPRESSION 3 0.0003
486 COLON CANCER 5 0.0003
487 MYOSITIS 3 0.0003
488 CRANIOCEREBRAL INJURY 1 0.0003
489 ANXIETY 94 0.0003
490 FOETAL GROWTH RESTRICTION 2 0.0003
491 GRAND MAL CONVULSION 3 0.0003
492 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
493 HEPATIC STEATOSIS 6 0.0003
494 PANCREATITIS 17 0.0003
495 INFUSION SITE EXTRAVASATION 2 0.0003
496 BASAL CELL CARCINOMA 5 0.0003
497 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
498 BLOOD BLISTER 1 0.0003
499 BLOOD CREATININE DECREASED 1 0.0003
500 MUSCLE ATROPHY 4 0.0003
501 METABOLIC ACIDOSIS 10 0.0003
502 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 15 0.0003
503 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
504 ACUTE KIDNEY INJURY 47 0.0003
505 BACTERIAL SEPSIS 1 0.0003
506 BRADYPHRENIA 2 0.0003
507 RENAL TUBULAR NECROSIS 3 0.0003
508 SOMNAMBULISM 2 0.0003
509 LIGAMENT SPRAIN 3 0.0003
510 BLADDER DISORDER 3 0.0003
511 HYPERGLYCAEMIA 11 0.0003
512 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
513 COGNITIVE DISORDER 14 0.0003
514 MENINGITIS 2 0.0003
515 ANXIETY DISORDER 1 0.0003
516 FACE OEDEMA 5 0.0003
517 CLOSTRIDIAL INFECTION 1 0.0003
518 HEPATIC FUNCTION ABNORMAL 11 0.0003
519 TOOTH ABSCESS 3 0.0003
520 B-CELL LYMPHOMA 1 0.0003
521 INFARCTION 2 0.0003
522 LUNG NEOPLASM MALIGNANT 12 0.0003
523 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
524 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
525 PARANOIA 5 0.0003
526 ORTHOSTATIC HYPOTENSION 5 0.0003
527 DRUG-INDUCED LIVER INJURY 9 0.0003
528 RIGHT VENTRICULAR FAILURE 2 0.0003
529 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
530 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
531 GRAFT VERSUS HOST DISEASE 2 0.0003
532 TONGUE DISORDER 2 0.0003
533 GASTROENTERITIS 4 0.0003
534 HEPATITIS 7 0.0003
535 PSYCHOTIC DISORDER 8 0.0003
536 HYPOPHOSPHATAEMIA 2 0.0003
537 HYPERTENSIVE CRISIS 3 0.0003
538 HEPATOTOXICITY 6 0.0003
539 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
540 FRACTURE 5 0.0003
541 PROCEDURAL COMPLICATION 2 0.0003
542 ELECTROLYTE IMBALANCE 3 0.0003
543 HYPOALBUMINAEMIA 2 0.0003
544 BRAIN FOG 4 0.0003
545 LYMPHADENOPATHY 9 0.0003
546 ATAXIA 3 0.0003
547 NASAL DISCOMFORT 2 0.0003
548 DISEASE RECURRENCE 12 0.0003
549 LOW BIRTH WEIGHT BABY 2 0.0003
550 ENCEPHALOPATHY 6 0.0002
551 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
552 GENERALISED OEDEMA 3 0.0002
553 MENSTRUAL DISORDER 2 0.0002
554 LIVER FUNCTION TEST ABNORMAL 7 0.0002
555 ACCIDENTAL EXPOSURE 1 0.0002
556 EOSINOPHIL COUNT INCREASED 2 0.0002
557 DYSSTASIA 7 0.0002
558 ASCITES 7 0.0002
559 SKIN PLAQUE 2 0.0002
560 HEPATIC CYTOLYSIS 3 0.0002
561 VITAMIN D DECREASED 2 0.0002
562 ALCOHOLISM 1 0.0002
563 DEPRESSION 53 0.0002
564 CARDIAC MURMUR 2 0.0002
565 PYELONEPHRITIS 2 0.0002
566 CHAPPED LIPS 1 0.0002
567 MENTAL DISORDER 10 0.0002
568 MYOCARDIAL INFARCTION 40 0.0002
569 URINE OUTPUT DECREASED 2 0.0002
570 ISCHAEMIC STROKE 4 0.0002
571 GASTROINTESTINAL INFECTION 2 0.0002
572 LOSS OF LIBIDO 2 0.0002
573 ANAL INCONTINENCE 2 0.0002
574 DRUG TOXICITY 3 0.0002
575 IMPAIRED GASTRIC EMPTYING 3 0.0002
576 BALANCE DISORDER 19 0.0002
577 PANIC ATTACK 8 0.0002
578 RETINAL DETACHMENT 2 0.0002
579 INCREASED TENDENCY TO BRUISE 2 0.0002
580 UROSEPSIS 2 0.0002
581 NERVE COMPRESSION 2 0.0002
582 DEFORMITY 2 0.0002
583 DIALYSIS 3 0.0002
584 MUSCULOSKELETAL DISORDER 4 0.0002
585 AFFECT LABILITY 2 0.0002
586 BRADYCARDIA 11 0.0002
587 HYPERCHOLESTEROLAEMIA 2 0.0002
588 FLUID OVERLOAD 3 0.0002
589 RESPIRATORY FAILURE 15 0.0002
590 ANAEMIA 39 0.0002
591 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
592 VITREOUS FLOATERS 2 0.0002
593 ABDOMINAL TENDERNESS 1 0.0002
594 SPINAL FRACTURE 4 0.0002
595 PREMATURE BABY 6 0.0002
596 TOXIC SKIN ERUPTION 2 0.0002
597 CELLULITIS 10 0.0002
598 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
599 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
600 CORONARY ARTERIAL STENT INSERTION 1 0.0002
601 DRUG DISPENSING ERROR 3 0.0002
602 DRUG ADMINISTRATION ERROR 6 0.0002
603 INITIAL INSOMNIA 2 0.0002
604 EAR DISCOMFORT 2 0.0002
605 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
606 PULMONARY HYPERTENSION 4 0.0002
607 PETECHIAE 2 0.0002
608 BLOOD LACTIC ACID INCREASED 1 0.0002
609 RENAL PAIN 2 0.0002
610 HIP FRACTURE 6 0.0002
611 ANAL FISSURE 1 0.0002
612 DYSARTHRIA 7 0.0002
613 DYSPNOEA EXERTIONAL 7 0.0002
614 OEDEMA 10 0.0002
615 NEUTROPENIA 25 0.0002
616 IRRITABILITY 11 0.0002
617 PHOTOSENSITIVITY REACTION 3 0.0002
618 DISCOMFORT 11 0.0002
619 VENTRICULAR FIBRILLATION 2 0.0002
620 BLOOD UREA INCREASED 3 0.0002
621 DYSPHAGIA 17 0.0002
622 THROMBOCYTOPENIA 20 0.0002
623 ANGIOPATHY 1 0.0002
624 BLOOD CALCIUM DECREASED 2 0.0002
625 STATUS EPILEPTICUS 2 0.0002
626 MITRAL VALVE INCOMPETENCE 2 0.0002
627 HEPATIC ENZYME INCREASED 12 0.0002
628 NEOPLASM 2 0.0002
629 CORONARY ARTERY BYPASS 1 0.0002
630 NIGHTMARE 6 0.0002
631 PANCREATIC CARCINOMA 5 0.0002
632 HYPERKALAEMIA 6 0.0002
633 CONDITION AGGRAVATED 52 0.0002
634 DRUG ERUPTION 3 0.0002
635 DEEP VEIN THROMBOSIS 11 0.0002
636 RENAL INJURY 5 0.0002
637 POLLAKIURIA 7 0.0002
638 CARDIAC PACEMAKER INSERTION 1 0.0002
639 ACCIDENT 2 0.0002
640 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
641 THYROID CANCER 2 0.0002
642 OSTEOARTHRITIS 7 0.0002
643 NEURALGIA 4 0.0002
644 CYST 2 0.0002
645 ILEUS 2 0.0002
646 PNEUMONIA ASPIRATION 4 0.0002
647 LEUKOPENIA 8 0.0002
648 PYREXIA 55 0.0002
649 SLEEP APNOEA SYNDROME 3 0.0002
650 CHOLESTASIS 3 0.0002
651 LOWER LIMB FRACTURE 3 0.0002
652 SLEEP DISORDER 11 0.0002
653 GLAUCOMA 3 0.0002
654 PRESCRIBED OVERDOSE 3 0.0002
655 PAIN 95 0.0002
656 LACTIC ACIDOSIS 5 0.0002
657 MOBILITY DECREASED 11 0.0002
658 MYALGIA 26 0.0002
659 MUCOSAL INFLAMMATION 4 0.0002
660 SEPSIS 17 0.0002
661 GASTRITIS 4 0.0002
662 GAIT DISTURBANCE 29 0.0002
663 CORONAVIRUS INFECTION 1 0.0002
664 UPPER LIMB FRACTURE 3 0.0002
665 VISUAL ACUITY REDUCED 5 0.0002
666 JAUNDICE 4 0.0001
667 INTENTIONAL SELF-INJURY 3 0.0001
668 LOSS OF CONSCIOUSNESS 19 0.0001
669 TOXICITY TO VARIOUS AGENTS 25 0.0001
670 LIMB INJURY 4 0.0001
671 DRUG EXPOSURE DURING PREGNANCY 5 0.0001
672 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
673 ABNORMAL LOSS OF WEIGHT 1 0.0001
674 CORONARY ARTERY OCCLUSION 2 0.0001
675 FALL 48 0.0001
676 MENTAL STATUS CHANGES 4 0.0001
677 LUNG DISORDER 7 0.0001
678 BACK PAIN 33 0.0001
679 SEASONAL ALLERGY 2 0.0001
680 URINARY TRACT INFECTION 24 0.0001
681 HYPOKINESIA 2 0.0001
682 PRODUCT PRESCRIBING ISSUE 3 0.0001
683 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
684 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
685 PRODUCT USE IN UNAPPROVED INDICATION 34 0.0001
686 CONFUSIONAL STATE 22 0.0001
687 CARDIOMYOPATHY 2 0.0001
688 ARTHROPOD BITE 1 0.0001
689 PULMONARY MASS 2 0.0001
690 PNEUMONIA 43 0.0001
691 HYPERTENSION 28 0.0001
692 DEVICE FAILURE 2 0.0001
693 EPILEPSY 4 0.0001
694 TINNITUS 6 0.0001
695 HIP ARTHROPLASTY 2 0.0001
696 BOWEL MOVEMENT IRREGULARITY 1 0.0001
697 SKIN DISCOLOURATION 6 0.0001
698 MUSCLE TWITCHING 3 0.0001
699 HYPOKALAEMIA 6 0.0001
700 DEVICE RELATED INFECTION 2 0.0001
701 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
702 ATRIOVENTRICULAR BLOCK 1 0.0001
703 MUSCULOSKELETAL CHEST PAIN 2 0.0001
704 CONCUSSION 1 0.0001
705 RENAL DISORDER 6 0.0001
706 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
707 PARAESTHESIA 20 0.0001
708 PRODUCT USE COMPLAINT 2 0.0001
709 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
710 BLOOD ALBUMIN DECREASED 1 0.0001
711 PRODUCTIVE COUGH 6 0.0001
712 HEPATIC CANCER 3 0.0001
713 BLISTER 7 0.0001
714 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
715 NIGHT SWEATS 4 0.0001
716 PRESYNCOPE 3 0.0001
717 PRODUCT DOSE OMISSION 8 0.0001
718 CHOLELITHIASIS 4 0.0001
719 BRONCHITIS 9 0.0001
720 CARDIO-RESPIRATORY ARREST 5 0.0001
721 ADVERSE EVENT 11 0.0001
722 PERICARDITIS 2 0.0001
723 CANDIDA INFECTION 2 0.0001
724 GASTRIC CANCER 3 0.0001
725 HAEMATEMESIS 3 0.0001
726 DIABETES MELLITUS 9 0.0001
727 MULTI-ORGAN FAILURE 2 0.0001
728 NEUROPATHY PERIPHERAL 11 0.0001
729 ABDOMINAL DISTENSION 12 0.0001
730 LOCAL SWELLING 2 0.0001
731 SPEECH DISORDER 6 0.0001
732 JOINT STIFFNESS 3 0.0001
733 DRUG INTOLERANCE 11 0.0001
734 HEAD DISCOMFORT 2 0.0001
735 CARDIAC FAILURE CONGESTIVE 9 0.0001
736 CEREBRAL HAEMORRHAGE 4 0.0001
737 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
738 WEIGHT DECREASED 31 0.0001
739 CHILLS 13 0.0001
740 LEUKOCYTOSIS 2 0.0001
741 SYNCOPE 11 0.0001
742 RESPIRATORY DISTRESS 3 0.0001
743 ABNORMAL DREAMS 3 0.0001
744 CONJUNCTIVITIS 2 0.0001
745 AMNESIA 7 0.0001
746 OFF LABEL USE 94 0.0001
747 APPENDICITIS 1 0.0001
748 HYPONATRAEMIA 6 0.0001
749 MUSCULAR WEAKNESS 12 0.0001
750 FEBRILE NEUTROPENIA 7 0.0001
751 COLITIS 4 0.0001
752 ATELECTASIS 1 0.0001
753 DYSTONIA 2 0.0001
754 AUTOIMMUNE DISORDER 1 0.0001
755 CHEST PAIN 19 0.0001
756 PALPITATIONS 12 0.0001
757 PREGNANCY 2 0.0001
758 BLOOD POTASSIUM DECREASED 3 0.0001
759 BRAIN INJURY 1 0.0001
760 CORONARY ARTERY DISEASE 3 0.0001
761 PRODUCT ADMINISTRATION ERROR 2 0.0001
762 ILL-DEFINED DISORDER 6 0.0001
763 VERTIGO 6 0.0001
764 CHEST DISCOMFORT 10 0.0001
765 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
766 ROAD TRAFFIC ACCIDENT 4 0.0001
767 AGITATION 7 0.0001
768 PRODUCT DOSE OMISSION ISSUE 28 0.0001
769 HEAD INJURY 3 0.0001
770 INSOMNIA 25 0.0001
771 IMPAIRED WORK ABILITY 2 0.0001
772 BREAST CANCER METASTATIC 1 0.0001
773 NAUSEA 73 0.0001
774 DIZZINESS 46 0.0001
775 BACK INJURY 1 0.0001
776 MALAISE 40 0.0001
777 COVID-19 16 0.0001
778 LIVER DISORDER 4 0.0001
779 DEHYDRATION 12 0.0001
780 NEOPLASM MALIGNANT 6 0.0001
781 GAIT INABILITY 3 0.0001
782 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
783 ADVERSE DRUG REACTION 8 0.0001
784 PANCREATITIS ACUTE 2 0.0001
785 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
786 CHROMATURIA 2 0.0001
787 HERPES ZOSTER 5 0.0001
788 DRY MOUTH 7 0.0001
789 ABDOMINAL PAIN 20 0.0001
790 ASTHENIA 32 0.0001
791 CARDIAC ARREST 7 0.0001
792 PULMONARY EMBOLISM 8 0.0001
793 COMA 4 0.0001
794 CHOLECYSTITIS 1 0.0001
795 BURSITIS 1 0.0001
796 CEREBRAL INFARCTION 2 0.0001
797 INJECTION SITE URTICARIA 2 0.0001
798 LIVER INJURY 2 0.0001
799 CARDIOMEGALY 1 0.0001
800 DYSGEUSIA 6 0.0001
801 PRODUCT STORAGE ERROR 7 0.0001
802 ABDOMINAL PAIN LOWER 2 0.0001
803 PRODUCT COMPLAINT 2 0.0001
804 DRUG DOSE OMISSION 13 0.0001
805 ERECTILE DYSFUNCTION 2 0.0001
806 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
807 HAEMATOMA 2 0.0001
808 SWELLING FACE 5 0.0001
809 RESPIRATORY TRACT INFECTION 2 0.0001
810 SEDATION 2 0.0001
811 BEDRIDDEN 1 0.0001
812 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
813 DISORIENTATION 3 0.0001
814 RASH 33 0.0001
815 DEPRESSED MOOD 4 0.0001
816 FEAR 2 0.0001
817 DISTURBANCE IN ATTENTION 4 0.0001
818 CONSTIPATION 16 0.0001
819 ACUTE HEPATIC FAILURE 1 0.0001
820 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
821 VISION BLURRED 10 0.0001
822 MEMORY IMPAIRMENT 10 0.0001
823 RESPIRATORY ARREST 2 0.0001
824 VOMITING 34 0.0001
825 ARTHROPATHY 4 0.0001
826 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
827 DEMENTIA 2 0.0001
828 CARPAL TUNNEL SYNDROME 1 0.0001
829 BURNING SENSATION 5 0.0001
830 TARDIVE DYSKINESIA 2 0.0001
831 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
832 DRUG INEFFECTIVE 93 0.0001
833 FLATULENCE 4 0.0001
834 CONVULSION 4 0.0001
835 CARDIOGENIC SHOCK 1 0.0001
836 LETHARGY 4 0.0001
837 FATIGUE 54 0.0001
838 SEIZURE 8 0.0001
839 PRODUCT USE ISSUE 13 0.0001
840 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
841 INTENTIONAL PRODUCT MISUSE 6 0.0001
842 URINARY INCONTINENCE 2 0.0001
843 WEIGHT INCREASED 15 0.0001
844 GASTROINTESTINAL DISORDER 6 0.0001
845 NO ADVERSE EVENT 12 0.0001
846 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
847 HYPOTENSION 13 0.0001
848 LIMB DISCOMFORT 2 0.0001
849 ANKLE FRACTURE 1 0.0001
850 FEMUR FRACTURE 2 0.0001
851 SOMNOLENCE 13 0.0001
852 BLOOD CHOLESTEROL INCREASED 3 0.0001
853 SWOLLEN TONGUE 2 0.0001
854 HEADACHE 40 0.0001
855 MIGRAINE 6 0.0001
856 INFLUENZA 7 0.0001
857 MOOD SWINGS 2 0.0001
858 ABSCESS 1 0.0001
859 INFLUENZA LIKE ILLNESS 5 0.0001
860 STAPHYLOCOCCAL INFECTION 2 0.0001
861 INFUSION RELATED REACTION 4 0.0001
862 ARTHRALGIA 25 0.0001
863 VIRAL INFECTION 2 0.0001
864 LIP SWELLING 2 0.0001
865 COAGULOPATHY 1 0.0001
866 FUNGAL INFECTION 2 0.0001
867 AGGRESSION 3 0.0001
868 URINARY RETENTION 2 0.0001
869 DEATH 51 0.0001
870 FLUID RETENTION 3 0.0001
871 HAEMATURIA 2 0.0001
872 DELIRIUM 2 0.0001
873 OEDEMA PERIPHERAL 7 0.0001
874 HAEMORRHAGE 6 0.0001
875 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
876 PLATELET COUNT DECREASED 6 0.0001
877 DRUG EFFECT INCOMPLETE 2 0.0001
878 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
879 BONE DISORDER 1 0.0001
880 SUICIDAL IDEATION 5 0.0001
881 NASOPHARYNGITIS 10 0.0001
882 DIARRHOEA 35 0.0001
883 BLOOD GLUCOSE ABNORMAL 1 0.0001
884 INJECTION SITE MASS 2 0.0001
885 NECK PAIN 3 0.0001
886 EPISTAXIS 4 0.0001
887 HYPOAESTHESIA 8 0.0001
888 CARDIAC DISORDER 5 0.0001
889 SWELLING 5 0.0001
890 BLOOD SODIUM DECREASED 1 0.0001
891 BLOOD URINE PRESENT 1 0.0001
892 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
893 HOSPITALISATION 8 0.0001
894 ATRIAL FIBRILLATION 5 0.0001
895 CHOKING 1 0.0001
896 DYSPNOEA 29 0.0001
897 DYSPEPSIA 5 0.0001
898 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
899 THERAPEUTIC RESPONSE DECREASED 3 0.0000
900 SUICIDE ATTEMPT 3 0.0000
901 DYSKINESIA 2 0.0000
902 BLINDNESS 2 0.0000
903 ABDOMINAL PAIN UPPER 10 0.0000
904 INCORRECT DOSE ADMINISTERED 11 0.0000
905 COMPLETED SUICIDE 4 0.0000
906 CEREBROVASCULAR ACCIDENT 8 0.0000
907 INTENTIONAL OVERDOSE 3 0.0000
908 RECTAL HAEMORRHAGE 2 0.0000
909 COUGH 13 0.0000
910 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
911 MUSCULOSKELETAL STIFFNESS 4 0.0000
912 ANGIOEDEMA 2 0.0000
913 PULMONARY OEDEMA 2 0.0000
914 THERAPY NON-RESPONDER 2 0.0000
915 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
916 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
917 ABDOMINAL DISCOMFORT 7 0.0000
918 BLOOD PRESSURE FLUCTUATION 1 0.0000
919 CONTUSION 4 0.0000
920 INTERSTITIAL LUNG DISEASE 2 0.0000
921 HYPOGLYCAEMIA 2 0.0000
922 PAIN IN EXTREMITY 12 0.0000
923 DRY EYE 2 0.0000
924 ILLNESS 4 0.0000
925 INFLAMMATION 2 0.0000
926 DECREASED APPETITE 9 0.0000
927 MUSCULOSKELETAL PAIN 2 0.0000
928 FEELING ABNORMAL 9 0.0000
929 BREAST CANCER FEMALE 1 0.0000
930 CARDIAC FAILURE 3 0.0000
931 THROMBOSIS 3 0.0000
932 DRUG EFFECT DECREASED 2 0.0000
933 OVERDOSE 8 0.0000
934 RASH PRURITIC 2 0.0000
935 DRUG ABUSE 3 0.0000
936 ALOPECIA 7 0.0000
937 SKIN EXFOLIATION 3 0.0000
938 EYE PAIN 2 0.0000
939 ASTHMA 4 0.0000
940 ANGINA PECTORIS 1 0.0000
941 PRODUCT SUBSTITUTION ISSUE 2 0.0000
942 DYSPHONIA 2 0.0000
943 SURGERY 2 0.0000
944 PRURITUS 13 0.0000
945 DISEASE PROGRESSION 4 0.0000
946 CATARACT 2 0.0000
947 STOMATITIS 2 0.0000
948 PLEURAL EFFUSION 2 0.0000
949 PERIPHERAL SWELLING 5 0.0000
950 OROPHARYNGEAL PAIN 3 0.0000
951 HYPERSENSITIVITY 6 0.0000
952 BLOOD GLUCOSE INCREASED 6 0.0000
953 BLOOD PRESSURE DECREASED 2 0.0000
954 URTICARIA 5 0.0000
955 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
956 ANGER 1 0.0000
957 FLUSHING 3 0.0000
958 PRODUCT QUALITY ISSUE 4 0.0000
959 SINUSITIS 3 0.0000
960 HAEMOGLOBIN DECREASED 3 0.0000
961 INJECTION SITE REACTION 2 0.0000
962 SKIN BURNING SENSATION 2 0.0000
963 CRYING 1 0.0000
964 UNDERDOSE 2 0.0000
965 HALLUCINATION 2 0.0000
966 HOT FLUSH 2 0.0000
967 UNEVALUABLE EVENT 2 0.0000
968 BLOOD PRESSURE INCREASED 4 0.0000
969 INJECTION SITE SWELLING 2 0.0000
970 ARTHRITIS 2 0.0000
971 ABNORMAL BEHAVIOUR 1 0.0000
972 INJECTION SITE BRUISING 2 0.0000
973 INJECTION SITE HAEMORRHAGE 2 0.0000
974 JOINT SWELLING 3 0.0000
975 DRUG WITHDRAWAL SYNDROME 2 0.0000
976 MUSCLE SPASMS 4 0.0000
977 BREAST CANCER 2 0.0000
978 ARRHYTHMIA 1 0.0000
979 BLOOD GLUCOSE DECREASED 1 0.0000
980 INFECTION 3 0.0000
981 ERYTHEMA 4 0.0000
982 TREMOR 3 0.0000
983 BONE PAIN 1 0.0000
984 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
985 VISUAL IMPAIRMENT 2 0.0000
986 ACNE 1 0.0000
987 INJECTION SITE PAIN 4 0.0000